MXPA99010640A - Sunscreen composition - Google Patents
Sunscreen compositionInfo
- Publication number
- MXPA99010640A MXPA99010640A MXPA/A/1999/010640A MX9910640A MXPA99010640A MX PA99010640 A MXPA99010640 A MX PA99010640A MX 9910640 A MX9910640 A MX 9910640A MX PA99010640 A MXPA99010640 A MX PA99010640A
- Authority
- MX
- Mexico
- Prior art keywords
- zinc oxide
- sunscreen
- sunscreen composition
- particle size
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 78
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 70
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 192
- 239000011787 zinc oxide Substances 0.000 claims abstract description 96
- 238000009472 formulation Methods 0.000 claims abstract description 64
- 239000002245 particle Substances 0.000 claims abstract description 37
- 239000000049 pigment Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000005855 radiation Effects 0.000 claims abstract description 9
- 230000037072 sun protection Effects 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims description 17
- 239000002184 metal Substances 0.000 claims description 17
- GVJRHAYBULCTSU-UHFFFAOYSA-I [Al+3].[Mg+2].OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC Chemical group [Al+3].[Mg+2].OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC.OC(C(=O)[O-])CCCCCCCCCCCCCCCC GVJRHAYBULCTSU-UHFFFAOYSA-I 0.000 claims description 15
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 claims description 12
- 229940072106 hydroxystearate Drugs 0.000 claims description 12
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 8
- 229960001679 octinoxate Drugs 0.000 claims description 8
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 claims description 6
- 230000000254 damaging effect Effects 0.000 claims description 4
- 230000009931 harmful effect Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 229920003958 FORMION® Polymers 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxyoctadecanoic acid Chemical class CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- RMFFCSRJWUBPBJ-UHFFFAOYSA-N 15-hydroxypentadecyl benzoate Chemical compound OCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RMFFCSRJWUBPBJ-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Abstract
The invention provides a sunscreen formulation including conventional UVB sunscreening agents and zinc oxide having an average particle size in the order of 150 to 800 nm. Preferably the zinc oxide used is pigment grade. Most preferably, zinc oxide prepared by the French process is used, although that produced by the American process is also suitable. The average particle size of the zinc oxide is most preferably in the order of 200-400 nm. Throughout this specification, the term"pigment grade"is used to define zinc oxide that has been produced by the French or American process. A further embodiment of the invention is a method of reducing or preventing the harmful effects of solar radiation on skin by applying the inventive sunscreen formulation. A further embodiment of the invention relates to a sunscreen composition having a sun protection factor greater than 30 including zinc oxide having an average particle size of 150 to 800 nm. A still further embodiment of the invention relates to a sunscreen composition which is susbstantially transparent upon application to the skin including zinc oxide having an average particle size of 150 to 800 nm.
Description
COMPOSITION OF SOLAR FILTER
DESCRIPTION OF THE INVENTION
This invention relates to sunscreen formions and, more especially to a sunscreen composition that includes zinc oxide. In recent years there has been an increased perseverance of the need to use sunscreens for the protection of exposed skin. Solar radiation, particly that of the ultraviolet region, is considered to be the cause of painful sunburn, discoloration of the skin-stains and cloth and is considered to promote skin aging. In addition, exposure to strong sunlight seems to be a significant contributor to skin cancer. It should be noted that solar ultraviolet radiation contains three types of rays: UV-A, UV-B and UV-C. While UV-C rays from the sun are absorbed by the atmosphere and therefore are not normally a problem, they can be produced in artificial sources, such as arc welding. Zinc oxide provides a high level of protection to REF rays: 32085 UV for the skin in the UV-A region. A commercial sunscreen formion should also provide protection in the UV-B region. There are many sunscreen formions known in the pharmaceutical and cosmetic industry. The commercialized formions are usually in the form of a cream or lotion and contain a number of active components designed to protect the user against various wavelengths of light. In addition, these commercial formions contain additional components that provide other aesthetic properties and desirable techniques. For example, moisturizers, fragrances and preservatives. "The ability of a sunscreen composition to protect the skin from the damaging effects of the sun is indicated by a sun protection factor
(SPF) The higher the SPF the greater the protection produced by the sunscreen. In Australia, the SPF of a sunscreen product should be evaluated and classified according to Australian Standard AS / NZS 2604: 1993. An SPF rating allows the user to calce the amount of time he can be exposed to UV rays without significant harmful effects. For example, an SPF of 4 allows the user to spend a lot of time in the sun 4 times normally before a sunburn occurs again. It is well known in the cosmetic industry that various metal oxides have a great effect in detecting UV rays penetrating the skin. In partic, zinc oxide is known for its ability to absorb and distinguish UV rays by virtue of Beers' Law and its use in sunscreens has been the subject of a number of patent applications. A brief description of these more relevant descriptions follows: AU-B-59365/94 (671189) (Colgate-Palmolive Company) describes a sunscreen composition comprising a water-in-oil emulsion, wherein the oil phase contains oxide of nano-sized zinc defined in this document as being particles in the range of 10 to 250 nm and polyethylene. The invention is described in the discovery of a synergistic interaction between the zinc oxide of a partic particle size, polyethylene and normal sunscreen agents such as those described on page 3, lines 6-8. US 5,032,390 (Kao Corportaion) recognizes the value of using zinc oxide having a particle size of 70 to 300 nm in sunscreen compositions to diffuse or absorb UV rays, particly those in the UV-A region. US 5,066,530 (Sumitomo Chemical Company) discloses the use of a sheet comprising a lamellar substance such as a matrix and a zinc oxide (50-500 nm). US 5,575,988 (Little Point Corporation) describes a combination of sunscreen and insect repellents. The sunscreen activity can be provided by using nanomated zinc oxide having a particle size of 300 nm or less. WO 93/23482 (The Boots Company PLC) describes the preparation of ink-coated metal oxides which include zinc oxide having a particle size of less than 500 nm. These coated metal oxides are used in sunscreen formulations. In the past it has been known to use zinc oxide having a larger particle size as a sunscreen agent in "zinc creams". These creams are white or can be colored with suitable pigments and dyes and retain their color after application on the skin. These may contain up to 28-32% by weight of zinc oxide. They are normally used in the form of a face paint, but they are not aesthetically acceptable for use on the total exposed skin area. While traditional zinc oxide-based sunscreens are thixotropic and non-transparent when applied to the skin of users, modern aesthetics demand compositions of better sensation and sight. It was generally thought that in order to provide an aesthetically acceptable sunscreen that is transparent
When applied, the zinc oxide used must be nanomized. This problem is discussed in AU-B-68039/90 (631704) (Johnson &Johnson Consumer
Products, Ine). As stated in that patent only when "the zinc oxide particles have an average particle size around, or less than,
50 nanometers the particles lose their white appearance. A sunscreen formulation that uses suitably nanomated zinc oxide should be invisible on the skin after application and thus is aesthetically acceptable. Such formulations may contain about 4-6% by weight of nanomized zinc oxide. However, the use of nanomated zinc oxide has disadvantages associated with its high cost which, in turn, is passed on to the cost of the sunscreen. In addition, the finely divided particles of zinc oxide tend to agglomerate and thus lower their SPF classification and produce a lower product. It is the object of the present invention to provide an improved sunscreen formulation that is less expensive and has an SPF as high as possible. This preferably has a large half-life and is aesthetically acceptable in order to be commercially viable. The sunscreen formulation is ideally cosmetically acceptable, non-toxic and non-irritating to the skin. It must be controllable in the sense of its dispersibility. The invention provides a sunscreen formulation that includes conventional UVB sunscreen agents and zinc oxide having an average particle size in the order of 150 to 800 nm. Preferably the zinc oxide used is pigment grade. More preferably, the zinc oxide prepared by the French process is used, although that produced by the American process is also suitable. The average particle size of the zinc oxide is more preferably in the order of 200-400 nm.
In all this specification, the term "pigment grade" is used to define the zinc oxide that has been produced by the French or American process. The processed zinc oxide is also known as "smoked" zinc oxide because of the process steps by which it is achieved. The "coarse" or "BP" grade is another term for the grade of zinc oxide used in the invention. The French and American processes are commonly known but are described, for example, in the article Mi tchni ck, M. A., "Zinc oxy, An Oí d Fri end to the Rescue", Cosmeti cs & Toil etri es, Vol 1 07 - October 1992. ~ Preferred formulations of the invention include one or more metal hydroxystearates. The metal tearate hydroxies used in the formulations of the invention are preferably magnesium-aluminum hydroxystearate and more preferably magnesium-aluminum hydroxystearate of the Gilugel ™ brand. The metal hydroxystearate is preferably present in an amount of 2-20% w / w, more preferably 5-15% w / w. Preferably, the composition may include active ingredients that provide additional protection from light in the UV-A or UV-C regions. The present invention is partially established on the unexpected discovery that when the pigment grade zinc oxide is combined with a magnesium-aluminum hydroxystearate, in particular Gilugel ™, the resulting sunscreen formulation does not retain the expected whiteness or pigmentation after application on the skin. This significant and surprising advantage is unexpected since the pigment grade zinc oxide usually has an average particle size in the order of 100 to 500 nm, results in a generally opaque film and is very visible on the skin when applied as a cream or lotion. The opacity of the ability to prevent the transmission of light either by reflection and / or absorption. The surface of the zinc oxide crystal effectively reflects the visible light. Therefore, the greater the number of surfaces, the greater the light reflected. Later, those smaller particles, with greater surface area per mass will reflect more light. This appears, however, when the particle size is plotted against the transmission, so as not to be completely correct. In particular, according to Figure 1, a graph taken from Mitchnick, M.A., "Zinc oxide, An Old Friend to the Rescue", Cosmetics &; Toiletries, Vol 107, October 1992., opacity to visible light reaches a maximum in particle size of approximately 250 nm. Particles smaller than this size actually transmit more light. It is postulated that this is because the smaller particles of 250 nm, besides reflecting light, also scatter it in all directions. Some of this scattered light is transmitted. The sunscreen formulation according to the invention is aesthetically acceptable despite including zinc oxide having a preferred average particle size in the order of 200 'to 400 nm shown in Figure 1 to transmit less light, it is say be more opaque. This surprising result is further contrasted against the existing industrial understanding illustrated in Figure 2 (from Spruce, SR, "Broad Spectrum protection with" Spectraveil "Zinc oxide and Titanium Dioxide Products-Formulation Efficacy of Zinc oxide", for Tioxide Specialties Ltd at the In-Cosmetics Meeting, Barcelona, 1994) that shows that "Fine Particle" or nanomized zinc oxide has a superior capacity to extinguish light at various wavelengths, than from pigment grade zinc oxide.
Second, the invention is partially established on the discovery that there appears to be a synergistic increase in the SPF classification provided by a sunscreen formulation containing zinc oxide, a conventional UVB sunscreen agent and metal hydroxystearate. It could have been expected normally that the SPF classification of the total sunscreen formulation containing zinc oxide, a UVB agent and magnesium-aluminum hydroxystearate could be the sum of the effect of agents having the sunscreen capacity present in the formulation and in particular the combination of Gilugel ™ and zinc oxide and the UVB agent. However, from the initial tests, the SPF of the total sunscreen formulation is significantly higher than that of the sum dp of the agents that have solar filter capacity. From a physical perspective, it is speculated that the magnesium-aluminum hydroxystearate in its capacity as an oil phase thickener, also acts to keep the sunscreen formulation in a layer of sufficient thickness that allows the Law of
Beer-Lambert can be exploited for the benefit of the user, particularly by the absorption of UVB light by the UVB filter agent present in the composition. The Beer-Lambert Law states that the intensity of radiation falls off exponentially with the thickness of the sample, and depends on the concentration of the absorbing species, in this case the UVB filter agent, and its ability to absorb light in the frequency that is used, in this case, UV light. In particular it is thought that if the length of the path of the UV light through the formulation can be maximized, the radiation reaching the surface of the skin is minimized. It is thought that pigment grade zinc oxide performs the function of path light extension. A schematic illustration of this principle, also applicable to titanium dioxide which is commonly used as a sunscreen together with or instead of zinc oxide, is provided by Figure 3. A further embodiment of the invention is a method for reducing or avoiding the damaging effects of solar radiation on the skin by applying the inventive sunscreen formulation. This is a method to reduce or prevent the damaging effects of solar radiation on the skin by applying a sunscreen formulation that includes zinc oxide having an average particle size in the order of 150 to 800 nm. Preferably the zinc oxide used in pigment grade as defined hereinabove. Preferably the sunscreen formulation will include one or more metal hydroxystearates, more preferably magnesium-aluminum hydroxystearate and more preferably magnesium-aluminum hydroxystearate of the Gilugel ™ brand. More preferably, the average particle size of the zinc oxide particles is 200-400 nm. A further embodiment of the invention relates to a sunscreen composition having a sun protection factor greater than 30 which includes zinc oxide having an average particle size of 150 to 800 nm. Preferably the zinc oxide used is pigment grade as defined hereinabove. Preferably the sunscreen formulation will include one or more metal hydroxystearates, more preferably magnesium-aluminum hydroxystearate and more preferably magnesium-aluminum hydroxystearate of the Gilugel ™ brand. More preferably, the average particle size of the zinc oxide particles is 200-400 nm. A still further embodiment of the invention relates to a sunscreen composition that is substantially transparent with skin application that includes zinc oxide having an average particle size of 150 to 800 nm. Preferably the zinc oxide used is pigment grade as defined hereinabove. Preferably the sunscreen formulation will include one or more metal hydroxystearates, more preferably magnesium-aluminum hydroxystearate and more preferably magnesium-aluminum hydroxystearate of the Gilugel ™ brand. More preferably, the average particle size of the zinc oxide particles is 200-400 nm. The amount of zinc oxide present in the formulation affects the SPF of the formulation. While the nanomized zinc oxide used in the prior art formulations is expensive, the pigment grade zinc oxide is not, and thus an upper limit is determined for aesthetic reasons only. A minimum amount of pigment grade zinc oxide is required since without it, or in the case where it is not properly dispersed throughout the formulation, it is found that insufficient diffraction of light occurs so that acceptable grades of absorption of harmful radiation that reaches the surface of the skin. It is preferable that the amount of zinc oxide present is in the range of about 0.05-25% w / w by weight. More preferably zinc oxide is present in the range of 0.5-15% w / w by weight. It has also been found that the sunscreen formulations according to the invention are sufficiently waterproof without the addition of a waterproof polymer as required, for example, in the formulations of AU-B-59365. / 94 (671189) in the name of the Colgate Palmolive Company discussed earlier herein. The sunscreen formulation can be constituted in any form. However, it is preferred that the sunscreen formulation is in the form of an emulsion, more particularly a water-in-oil emulsion. Emulsions are a useful and effective carrier for zinc oxide. The zinc oxide may be suspended in the oil phase of the emulsion. The sunscreen formulation is preferably sold in any cosmetically acceptable form, such as a lotion, cream, gel or oil. It is preferred to use an emulsion when a sunscreen formulation is produced in the form of a cream, gel or lotion for the purposes of sensation and dispersibility. Some examples of ingredients that are active in the UVB region include titanium oxide, oxybenzene, octyl salicylate, octyl methoxycinnamate, octyl dimethyl p-aminobenzoic acid, octocrylene (2-ethylhexyl-2-cyano-3, 3-diphenylacrylate) , methyl benzylidene camphor, 2-phenyl-benzimidazole-5-sulfuric acid, benzophenone-2, benzophenone-6, benzophenone-12, benzophenone-3, benzophenone-4, benzophenone-8, DEA methoxycinnamate, ethyl dihydroxypropyl PABA, PABA of glyceryl, homosalate, menthyl anthranilate, octocrylene, PABA, phenylbenzimidazole sulfonic acid, TEA salicylate, isopropyl dibenzoyl methane, butyl methoxy-dibenzoylmethane, ethacrylene, PABA PEG-25, octyl triazone, wax wax beline, yellow beeswax filtered and orange wax. Preferred UVB absorbers according to the invention are octyl methoxycinnamate and methylbenzylidene camphor. These UVB protective components can be present in an amount of 0-15% w / w, preferably 2.0-8.0% w / w. In addition to the known agents that have a synergistic effect they can also be included in the sunscreen formulation. For example, the use of polyethylene in the sunscreen formulations containing zinc oxide and a number of the above sunscreen agents have been shown to synergistically improve the SPF classification of the total formulation. Other known ingredients commonly used in sunscreens may be added to the sunscreen formulation of the invention. Examples of such ingredients include emollients, dispersants, emulsifiers, stabilizers, humectants, antioxidants, preservatives and agents which provide water resistance, improve the "feel" for the skin and aid in the formation of the film, perfumes and dyes. they are isopropyl myristate, isopropyl palmitate, liquid paraffin, alkyl benzoate of 12 to 15 carbon atoms, fatty acid esters, triglycerides. Examples of dispersants include lecithin and solulate PB20. Any suitable emulsifiers can be used. Exemplary emulsifiers are ethoxylated fatty alcohols, acids and their esters, sorbitan esters, ethoxylated glycerides, glyceryl monostearate, polysorbates, cetyldimethicone copolyols and cyclomethicone / -dimethicone polyols. Preferred emulsifiers according to the invention are Arlacel 989MR and Abil WE 09MR which may be present in an amount of 1.0-10% w / w, preferably 2.0-8.0% w / w. Preferred stabilizers include magnesium sulfate, sodium chloride and sodium citrate. The preferred humectants are glycerin,
1, 3-butylene glycol, propylene glycol, D-panthenol, stearic acid, stearyl alcohol, oleic acid, octyl dodecanol, lanolin and alcohols and lanolin oils and dimethicone silicone. Several antioxidants can be included in the formulation. Examples are butylated hydroxytoluene and tocopherol. It is also desirable to include one or more preservatives in the formulation. Examples of suitable preservatives include bronopol, imidazolidinyl urea, diazolidinyl urea, sodium dehydroacetate, phenoxyethanol and parabens. A number of other agents useful in the formulation may be included. For example agents for water resistance such as PVP hexadecene copolymer and silicone oil, skin improving agents such as cyclomethicone and film-forming agents such as polyethylene and alkylated polyvinylpyrrolidone.
EXAMPLES OF THE INVENTION The invention is further illustrated by, but not limited to, the following examples.
Example 1
A test formulation was prepared by combining pigment grade zinc oxide (10% by weight) with octyl methoxycinnamate (7.5% by weight). The formulation was found to have an SPF before swimming (measured according to the standard referred to above herein) of 41.
Examples 2 - 7
The test formulations were prepared according to the following table, and the SPF is measured before swimming (measured as described hereinabove). The results are also tabulated.
It will be appreciated that example 2 in which the pigment grade zinc oxide is not present has a relatively low SPF of 16.0. Example 6 does not incorporate metal hydroxystearate, but zinc oxide at 5% w / w has an SPF of 14.1 while example 5 includes both zinc oxide at 5% w / w and Gilugel ™ at 11% p / p has an SPF of 34.2. All formulations are transparent when applied to the user's skin. The commercial form of the formulation according to the invention (example 4) contains 7.5% of octyl methoxycinnamate and 5.0% of pigment grade zinc oxide produces an SPF before swimming of more than 41.3, an SPF after swimming (after 2 hours of immersion in water) of more than 38.9, and an SPF after swimming (after 4 hours of immersion in water) of 31.
Examples 8 - 12
The examples are tabulated below in which the formulations are identical regardless of the percentage w / w of the zinc oxide present in the formulations. In each formulation a UVB agent has been used as it has a metal hydroxystearate. SPF has been generated when tested on human subjects.
Example Number% w / w of Zinc Oxide Grade Pigment Classification of SPF
8 0.5 25. 0 9 1.0 28. 2 10 2.0 25. 0 11 4.0 41. 5 12 3.0 + 2.0% zinc oxide 25. 0 nanamide coated with silicone
The composition of the solar filter with 5% zinc oxide pi-grade according to the invention produces an SPF of 41 or more, as does the sunscreen having pigment-grade zinc oxide at 4% of Example 11 in the table previously described. It is evident that the addition of the silicon coated nanomized zinc oxide in example 12 can in fact be subtracted from the SPF of the formulation rather than being added thereto. It is also evident that nanomized zinc oxide does not serve to diffract UV light as apparently made by pigment grade zinc oxide. A very small amount of pigment grade zinc oxide (0.5%) is shown to substantially strengthen the SPF of the formulation.
Examples 13-15
As an alternative to the octyl methoxycinnamate used in Examples 4-7, tests are also performed using Methyl Benzylidene Camphor (MBC) as the UVB absorbent sunscreen component. The SPF classifications are determined by application of the formulations to humans, which are identical but for the indicated variations and include magnesium-aluminum hydroxystearate.
Number of% w / w% of MBC Classification of SPF Example zinc oxide Before Swimming After Swimming 2 h
13 10.00 4 > 39.4 37.7 14 0 4 16.0 15 5.0 4 28.0
It is thus shown that the presence of the pigment grade zinc oxide in the formulations together with a UV absorbing compound and magnesium-aluminum hydroxystearate produces the SPF which is substantially greater than that which belongs to the formulations in which there is no oxide zinc grade pigment present.
Examples 16 - 19
These examples demonstrate the apparent synergy that occurs between the metal hydroxystearate, the pigment grade zinc oxide and the UVB absorbing agent in the compositions according to the invention. Example 16 is absent from the UVB absorbing agent. It is postulated that in this case, the composition is able to diffract the UV light but does not allow it to be absorbed due to the absence of the UVB absorbent component. Example 17 demonstrates the absence of the metal hydroxystearate. In this case, it is thought that the physical structure of the formulation collapses, and little or no absorption can occur. Example 18 demonstrates the absence of pigment grade zinc oxide. In this case, none of the formulation acts to diffract light through the formulation. It can be seen in Example 19 that the total formulation gives an SPF much greater than the additive effects of the three components.
Ingredient Ejepplo 16 Ejepplo 17 Ejenplo 18 Ejepplo 19% p / p% p / p% p / p% p / p
Abil WE 99 5.0 5.0 5.0 5.0
Finsolv TN 6.5 6.5 6.5 6.5
Octyl methoxycinnamate 0 0.00 7.5 7.5 7.5
Isopropyl Palmitate 2 255..00 19.7 22.5 17.5
Paraben esters 0.3 0.3 0.3 0.3
Gilugel OS 11.0 0.0 11.0 11.0
Octyl stearate 0.0 8.8 0.0 0.0
Propylene glycol 2.0 2.0 2.0 2.0
Phenoxyethanol 0.6 0.6 0.6 0.6
Methyl paraben 0.1 0.1 0.1 0.1
Water 44.1 44.1 44.1 44.1
Zinc oxide 5.0 5.0 0.0 5.0
Sodium Chloride 0.4 0.4 0.4 0.4 Total 100 100 100 100 SPF before swimming 3.4 12.8 16.0 > 41.3 It will be appreciated by an expert to handle a variety of other ingredients that can be included in the formulations and the invention includes such formulations. In addition, a variety of the above ingredients can be replaced by commonly accepted substitute ingredients. The invention also includes formulations wherein substitute ingredients have been used. Finally, as set forth above, the examples illustrate but do not limit the present invention. It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Claims (19)
- Having described the invention as above, the content of the following claims is claimed as property: 1. A sunscreen formulation, characterized in that it includes at least one UVB sunscreen agent and zinc oxide having an average particle size of 150 to 800 nm.
- 2. A sunscreen formulation according to claim 1, characterized in that the zinc oxide is pigment grade zinc oxide.
- 3. A sunscreen composition according to claim 1 or 2, characterized in that it also includes at least one metal hydroxystearate in a synergistically effective amount.
- 4. A sunscreen composition according to claim 3, characterized in that the metal hydroxystearate is magnesium-aluminum hydroxystearate.
- 5. A sunscreen composition according to claim 3 or 4, characterized in that the metal hydroxystearate is present in an amount of 2-20% w / w.
- 6. A sunscreen composition according to any of claims 1-5, characterized in that the UVB sunscreen agent is selected from the group consisting of octyl methoxycinnamate and methylbenzylidene camphor.
- 7. A sunscreen composition according to any of claims 1 to 6, characterized in that the zinc oxide is present in an amount of 0.05-25% w / w.
- 8. A sunscreen composition according to any of claims 1 to 7, characterized in that the zinc oxide is present in an amount of 0.5-15% w / w.
- 9. A sunscreen composition according to any of claims 3 to 8, characterized in that it includes pigment grade zinc oxide, octyl methoxycinnamate and magnesium-aluminum hydroxystearate.
- 10. A sunscreen composition according to any of claims 1 to 9, characterized in that the average particle size of the zinc oxide is 200-400 nm.
- 11. A sunscreen composition, characterized in that it has a sun protection factor greater than 30 which includes zinc oxide having an average particle size of 150 to 800 nm.
- 12. A sunscreen composition according to claim 11, characterized in that the zinc oxide is pigment grade.
- 13. A sunscreen composition according to claim 11 or 12, characterized in that it also includes at least one metal hydroxystearate in a synergistically effective amount.
- 14. A sunscreen composition, characterized in that it is substantially transparent with the application to the skin including zinc oxide having an average particle size of 150 to 800 nm.
- 15. A sunscreen composition according to claim 14, characterized in that the zinc oxide is pigment grade.
- 16. A sunscreen composition according to claim 14 or 15, characterized in that it also includes at least one metal hydroxystearate in a synergistically effective amount.
- 17. A method to reduce or avoid the damaging effects of solar radiation on the skin by applying to the skin requiring such treatment a sunscreen formulation, characterized in that it includes zinc oxide having an average particle size in the order of 150 to 800 nm.
- 18. A method according to claim 17, characterized in that the zinc oxide is pigment grade.
- 19. A method according to claim 17 or 18, characterized in that the sunscreen composition further includes a metal hydroxystearate in a synergistically effective amount.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| POPO6889 | 1997-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA99010640A true MXPA99010640A (en) | 2000-08-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6267949B1 (en) | Sunscreen composition | |
| EP1181000B1 (en) | A method for obtaining photostable sunscreen compositions | |
| CA2526536C (en) | Sunscreen composition | |
| DE69917277T2 (en) | SUNSCREEN | |
| US5607664A (en) | Photoprotective/cosmetic compositions comprising UV-A and/or UV-B sunscreens and polymers compatible therewith | |
| JP3643924B2 (en) | Photoprotective composition containing benzylidene camphor and / or dibenzoylmethane and / or triazine and dialkyl tartrate and cosmetic use thereof | |
| PH26914A (en) | Photoprotection compositions having reduced dermal irritation | |
| WO2009029931A2 (en) | Sunless tanning composition with photostabilized sunscreen | |
| WO2009102649A1 (en) | Photoprotective compositions with glycol and styrene/acrylate copolymer | |
| CA2390756A1 (en) | Sunscreen compositions containing a dibenzoylmethane derivative | |
| WO2002017873A1 (en) | Sunscreen compositions containing a dibenzoylmethane derivative and a triazine derivative | |
| AU2020230223B2 (en) | Sprayable sunscreen composition | |
| US6174518B1 (en) | Photoprotective/cosmetic compositions comprising w/o/w stable triple emulsions | |
| US6294156B1 (en) | Compositions with enhanced photoprotective effect and method for using same | |
| KR101408631B1 (en) | Moose-type ultraviolet ray cosmetic composition | |
| Levy | UV filters | |
| AU730661B2 (en) | Sunscreen composition | |
| MXPA99010640A (en) | Sunscreen composition | |
| KR102870201B1 (en) | Effective sunscreen composition comprising diethylamino hydroxybenzoyl hexyl benzoate and butyl methoxydibenzoylmethane | |
| WO2025146351A1 (en) | Cosmetic composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine | |
| AU2004247065B2 (en) | Sunscreen composition | |
| GB2437055A (en) | Sunscreen composition | |
| DE19750718C1 (en) | Improving the photo protection performance of cosmetic preparations containing UV filter substances |